85 related articles for article (PubMed ID: 28095215)
1. Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia.
Saavedra JM; Ito T; Nishimura Y
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S102-S109. PubMed ID: 28095215
[No Abstract] [Full Text] [Related]
2. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation.
Schulz R; Heusch G
J Hypertens Suppl; 2006 Mar; 24(1):S123-9. PubMed ID: 16601565
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment with candesartan protects from cerebral ischaemia.
Ito T; Nishimura Y; Saavedra J
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):174-9. PubMed ID: 11881119
[TBL] [Abstract][Full Text] [Related]
4. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
Zhou J; Pavel J; Macova M; Yu ZX; Imboden H; Ge L; Nishioku T; Dou J; Delgiacco E; Saavedra JM
Stroke; 2006 May; 37(5):1271-6. PubMed ID: 16601219
[TBL] [Abstract][Full Text] [Related]
5. The role of angiotensin receptor subtypes in cerebrovascular regulation in the rat.
Näveri L
Acta Physiol Scand Suppl; 1995; 630():1-48. PubMed ID: 8610501
[TBL] [Abstract][Full Text] [Related]
6. Central inhibition of AT1receptors by eprosartan--in vitro autoradiography in the brain.
Muders F; Palkovits M; Bahner U; Kirst I; Elsner D; Jandeleit-Dahm K
Pharmacol Res; 2001 Mar; 43(3):251-5. PubMed ID: 11401417
[TBL] [Abstract][Full Text] [Related]
7. [Are the antagonists of angiotensin II AT1 receptors protectors of the kidney?].
Deray G
Arch Mal Coeur Vaiss; 1999 Jul; 92(7):903-7. PubMed ID: 10443311
[TBL] [Abstract][Full Text] [Related]
8. Cumulative effects of AT1 and AT2 receptor blockade on ischaemia-reperfusion recovery in rat hearts.
Ryckwaert F; Colson P; Guillon G; Foëx P
Pharmacol Res; 2005 Jun; 51(6):497-502. PubMed ID: 15829428
[TBL] [Abstract][Full Text] [Related]
9. AT1 Angiotensin receptors-vascular and renal epithelial pathways for blood pressure regulation.
Chen D; Coffman TM
Curr Opin Pharmacol; 2015 Apr; 21():122-6. PubMed ID: 25687370
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II: multitasking in the brain.
Saavedra JM; Benicky J; Zhou J
J Hypertens Suppl; 2006 Mar; 24(1):S131-7. PubMed ID: 16601566
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A
Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445
[TBL] [Abstract][Full Text] [Related]
12. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
Takemori K; Ishida H; Ito H
Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533
[TBL] [Abstract][Full Text] [Related]
13. Ischemic injury in experimental stroke depends on angiotensin II.
Walther T; Olah L; Harms C; Maul B; Bader M; Hörtnagl H; Schultheiss HP; Mies G
FASEB J; 2002 Feb; 16(2):169-76. PubMed ID: 11818364
[TBL] [Abstract][Full Text] [Related]
14. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.
Yamakawa H; Jezova M; Ando H; Saavedra JM
J Cereb Blood Flow Metab; 2003 Mar; 23(3):371-80. PubMed ID: 12621312
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury.
Li J; Culman J; Hörtnagl H; Zhao Y; Gerova N; Timm M; Blume A; Zimmermann M; Seidel K; Dirnagl U; Unger T
FASEB J; 2005 Apr; 19(6):617-9. PubMed ID: 15665034
[TBL] [Abstract][Full Text] [Related]
16. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
[TBL] [Abstract][Full Text] [Related]
17. Up- and down-regulation of angiotensin II AT1-A and AT1-B receptors in afferent and efferent rat kidney arterioles.
Razga Z; Nyengaard JR
J Renin Angiotensin Aldosterone Syst; 2008 Dec; 9(4):196-201. PubMed ID: 19126659
[TBL] [Abstract][Full Text] [Related]
18. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
Kobori H; Nangaku M; Navar LG; Nishiyama A
Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
[TBL] [Abstract][Full Text] [Related]
19. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
Singh N; Sharma G; Singh N; Hanif K
Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
